Spruce Biosciences, Inc.
NASDAQ: SPRB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Javier Szwarcberg
- Employees
- 20
- Headquarters
- Daly City, United States
- IPO year
- 2020
- Market cap
- $71.2M
- Website
- https://www.sprucebiosciences.com
Loading SPRB…
Loading profile data…Frequently asked questions about SPRB
What does Spruce Biosciences, Inc. (SPRB) do?
Spruce Biosciences, Inc., founded in 2014 and situated in Daly City, California, operates as a biopharmaceutical enterprise. Its primary objective is to advance and bring to market innovative treatments, particularly for uncommon endocrine conditions. A central component of its therapeutic pipeline is tildacerfont, a non-steroidal drug candidate...
Where does SPRB trade?
Spruce Biosciences, Inc. (SPRB) trades on the NASDAQ Capital Market.
What sector is SPRB in?
Spruce Biosciences, Inc. (SPRB) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Spruce Biosciences, Inc.?
Javier Szwarcberg is the chief executive officer of Spruce Biosciences, Inc. (SPRB).
Where is Spruce Biosciences, Inc. headquartered?
Spruce Biosciences, Inc. is headquartered in United States.
Does SPRB pay a dividend?
Spruce Biosciences, Inc. (SPRB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SPRB go public?
Spruce Biosciences, Inc. (SPRB) completed its initial public offering in 2020.